The North America vitamin K2 market is experiencing significant growth, projected to surge from US$ 63.89 million in 2022 to US$ 494.38 million by 2030, demonstrating an impressive CAGR of 29.1% during this period. This substantial expansion is primarily driven by the increasing prevalence of cardiovascular disease (CVD) and the growing adoption of nutraceutical supplements.
Vitamin K2: A Key Player in Cardiovascular Health
Cardiovascular disease remains a major global health concern, with rising cases attributed to an aging population, sedentary lifestyles, and poor dietary habits. Alarmingly, the World Health Organization reports approximately 17.9 million CVD-related deaths globally each year.
📚Download Full PDF Sample Copy of Market Report @
https://www.businessmarketinsights.com/sample/BMIRE00029720
Vitamin K2, or menaquinone, is gaining recognition for its potential role in cardiovascular health, particularly its ability to regulate calcium metabolism. A crucial aspect of this is its impact on arterial calcification, where calcium deposits accumulate in arterial walls, contributing to atherosclerosis—a primary cause of CVD. Vitamin K2 helps inhibit this process by activating proteins that control calcium deposition, thereby reducing the risk of atherosclerosis and related cardiovascular disorders.
Observational studies support the link between vitamin K2 intake and improved CVD outcomes. For instance, a study in the Journal of Nutrition indicated that higher vitamin K2 intake was associated with a lower risk of coronary heart disease mortality. While these studies don’t establish a definitive cause-and-effect, they highlight vitamin K2’s potential as an adjunctive therapy or preventive measure alongside crucial lifestyle modifications. These modifications include adopting a balanced diet, maintaining a healthy weight, engaging in regular physical activity, managing blood pressure and cholesterol, and quitting smoking.
North America Market Dynamics
The North America vitamin K2 market encompasses the US, Canada, and Mexico. While the rising prevalence of CVD and bone deformities like osteoporosis in adults and newborns fuels market growth, limited awareness regarding vitamin K2’s benefits remains a hindering factor.
The US holds the largest share of the North American vitamin K2 market. This is due to the increasing incidence of cardiovascular diseases and orthopedic disorders, where vitamin K2 plays a vital role in enhancing calcium absorption for better cardiac and bone health. The Centers for Disease Control and Prevention (CDC) reported approximately 695,000 heart disease deaths in the US in 2021, with coronary heart disease being the most common type.
Furthermore, strategic developments within the US market, such as product launches, acquisitions, and mergers, are contributing to its expansion. A notable example is Kappa Bioscience’s October 2022 launch of K2Vital, the first USDA organic-certified, all-trans, all-bioactive vitamin K2-MK7 for oil-based health applications in the US market. These factors collectively indicate a robust growth trajectory for the vitamin K2 market in the US.
Strategic insights into the North American vitamin K2 market provide a data-rich view of the competitive landscape, highlighting emerging trends, leading players, and regional subtleties. With this analysis, stakeholders can uncover underserved niches, shape distinctive value propositions, and stay ahead of market shifts. By harnessing advanced analytics and maintaining a forward-looking outlook, investors, manufacturers, and other participants can position themselves for sustained growth and profitability in this dynamic sector. In short, robust strategic insights transform complex market data into clear, actionable guidance that drives long-term success.
Market leaders and key company profiles
ï‚·Â Anderson Global Group LLC
ï‚·Â Balchem Corp
ï‚·Â BASF SE
ï‚·Â Glanbia Plc
ï‚·Â International Flavors & Fragrances Inc
ï‚·Â Koninklijke DSM NV
ï‚·Â Lesaffre et Cie SA
ï‚·Â Lonza Group AG
ï‚·Â Novozymes AS
North America Vitamin K2 Regional Insights
The geographic scope of the North America Vitamin K2 refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
North America Vitamin K2 Market Segmentation Overview
The North America vitamin K2 market is comprehensively segmented across several key dimensions: product, dosage forms, source, application, and country.
Product Segmentation
The market for vitamin K2 in North America is broken down into three main product categories:
- MK-4
- MK-7
- Combination Drugs
In 2022, the MK-7 segment held the largest share of the market.
Dosage Form Segmentation
Vitamin K2 is available in various dosage forms in North America, including:
- Capsules & Tablets
- Powder
- Oils
The powder segment accounted for the largest market share in 2022.
Source Segmentation
The North America vitamin K2 market is supplied from two primary sources:
- Natural
- Synthetic
The natural segment held a larger share of the market in 2022.
Application Segmentation
Vitamin K2 finds application across several sectors in North America:
- Pharmaceuticals
- Nutraceuticals and Food
- Others
The pharmaceuticals segment dominated the market in terms of application in 2022.
Country Segmentation
Geographically, the North America vitamin K2 market is segmented into:
- US
- Canada
- Mexico
The US was the leading country in the North America vitamin K2 market in 2022.
Key Market Players
Several prominent companies are major players in the North America vitamin K2 market. These include:
- Anderson Global Group LLC
- Balchem ​​Corp.
- BASF SE
- Glanbia Plc
- International Flavors & Fragrances Inc
- Royal DSM NV
- Lesaffre and Co. SA
- Lonza Group AG
- Novozymes AS
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Défense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
Author’s Bio
Akshay
Senior Market Research Expert at Business Market Insights